Infections in patients with acute myeloid leukemia

被引:1
|
作者
Ehrlich, Sabine [1 ,4 ]
Spiekermann, Karsten [2 ]
Grothe, Jan Hendrik [3 ]
Stemler, Jannik [3 ]
机构
[1] Klinikum Univ Munchen, Hamatol & Onkol, Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Med Klin & Poliklin 3, Munich, Germany
[3] Uniklin Koln, Cologne, Germany
[4] Klinikum Univ Munchen, Med Klin & Poliklin 3, Marchioninistr 15, D-81377 Munich, Germany
关键词
acute myeloid leukemia; neutropenic fever; invasive fungal disease; DISEASES WORKING PARTY; ESCMID-ASTERISK GUIDELINE; NEUTROPENIC PATIENTS; GERMAN SOCIETY; HEMATOLOGICAL MALIGNANCIES; PRIMARY PROPHYLAXIS; FEVER; MANAGEMENT; DIAGNOSIS; CHEMOTHERAPY;
D O I
10.1055/a-1873-4858
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Infections represent one of the most frequent complications during therapy of acute myeloid leukemia (AML). In addition to associated prolonged phases of neutropenia, damage to the mucosal barrier by cytotoxic agents favors infections caused by endogenous pathogens. The source often remains unknown with bacteremia being the most common evidence of infection. Infections with gram-positive bacteria predominate, however, infections with gram-negative bacteria more often lead to sepsis and death. Due to prolonged neutropenia, patients with AML are furthermore at risk for invasive fungal infections. Viruses, on the other hand, are rarely the cause of neutropenic fever. Because of the limited inflammatory response in neutropenic patients, fever is often the only sign of infection and therefore always represents a hematologic emergency. Prompt diagnosis and initiation of an adequate anti-infective therapy are critical to avoid progression to sepsis and possibly death.
引用
收藏
页码:467 / 473
页数:7
相关论文
共 50 条
  • [31] Treatment of acute myeloid leukemia in older patients
    Roboz, Gail J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (03) : 285 - 295
  • [32] Peptide Vaccination in Patients with Acute Myeloid Leukemia
    Schmitt, M.
    Schmitt, A.
    Casalegno-Garduno, R.
    ANNALS OF HEMATOLOGY, 2011, 90 : S66 - S68
  • [33] The Treatment of Elderly Patients With Acute Myeloid Leukemia
    Krug, Utz
    Buechner, Thomas
    Berdel, Wolfgang E.
    Mueller-Tidow, Carsten
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2011, 108 (51-52): : 863 - U11
  • [34] Management of acute myeloid leukemia in elderly patients
    Hiddemann, W
    Kern, W
    Schoch, C
    Fonatsch, C
    Heinecke, A
    Wörmann, B
    Büchner, T
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) : 3569 - 3576
  • [35] Therapy of acute myeloid leukemia in elderly patients
    Wedding, U
    Höffken, K
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2001, 34 (04): : 269 - 276
  • [36] TEMPERATURE INSTABILITY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Cohen, Avi
    Ehteshami-Afshar, Solmaz
    Tsang, Derek
    Valda-Toro, Patricia
    Lee, Seohyuk
    Avery, Chace
    Kahn, Peter
    Dela Cruz, Charles
    Gautam, Samir
    CHEST, 2020, 158 (04) : 709A - 709A
  • [37] Treatment of Elderly Patients With Acute Myeloid Leukemia
    Xavier Thomas
    Caroline Le Jeune
    Current Treatment Options in Oncology, 2017, 18
  • [38] The challenge of acute myeloid leukemia in older patients
    Sekeres, MA
    Stone, RM
    CURRENT OPINION IN ONCOLOGY, 2002, 14 (01) : 24 - 30
  • [39] INDUCTION CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Lee, J. -H.
    Joo, Y. -D.
    Kim, H.
    Bae, S. H.
    Kim, M. K.
    Zang, D. Y.
    Lee, J. -L.
    Lee, G. W.
    Lee, J. -H.
    Park, J. -H.
    Kim, D. -Y.
    Lee, W. -S.
    Ryoo, H. M.
    Hyun, M. S.
    Kim, H. J.
    Min, Y. J.
    Lee, K. -H.
    ANNALS OF ONCOLOGY, 2012, 23 : 24 - 24
  • [40] Azacitidine for the treatment of patients with acute myeloid leukemia
    Maurillo, Luca
    Venditti, Adriano
    Spagnoli, Alessandra
    Gaidano, Gianluca
    Ferrero, Dario
    Oliva, Esther
    Lunghi, Monia
    D'Arco, Alfonso M.
    Levis, Alessandro
    Pastore, Domenico
    Di Renzo, Nicola
    Santagostino, Alberto
    Pavone, Vincenzo
    Buccisano, Francesco
    Musto, Pellegrino
    CANCER, 2012, 118 (04) : 1014 - 1022